Takeda Pharmaceutical Insider Trades
NYSE: TAKHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 20 · $13.09M
- Shares bought / sold
- 0 / 749.34K
- Net activity
- Net selling $13.1 million
Takeda Pharmaceutical insider activity
Over the last 12 months, Takeda Pharmaceutical insiders reported 41 transactions on SEC Form 4: 0 open-market purchases and 20 sales. Insiders bought $0 and sold $13.1 million worth of stock, for net insider selling of $13.1 million. The largest seller was Plump Andrew Stewart, with $5.3 million in reported sales.
The most recent filing shows Duprey Lauren Rusckowski (Chief Transformation Officer) selling 34,535 shares at $18.54 on Sep 14, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put TAK's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
TAK insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 14, 2026 | Duprey Lauren RusckowskiChief Transformation Officer | Sale | 34,535 | $640.28K | Form 4 |
| Sep 2, 2026 | Plump Andrew StewartPresident, R&D | Sale | 116,191 | $2.15M | Form 4 |
| Aug 19, 2026 | Plump Andrew StewartPresident, R&D | Sale | 19,651 | $363.35K | Form 4 |
| Aug 18, 2026 | Greenway Nicola Deidre PetalChief Human Resources Officer | Sale | 12,980 | $235.12K | Form 4 |
| Aug 11, 2026 | Shannon Elaine MaryPres., Global Supply & Quality | Sale | 20,363 | $357.37K | Form 4 |
| Aug 10, 2026 | Kim Julie So-YoungPresident and CEO | Sale | 89,090 | $1.52M | Form 4 |
| Aug 10, 2026 | Greenway Nicola Deidre PetalChief Human Resources Officer | Sale | 6,774 | $115.84K | Form 4 |
| Aug 10, 2026 | Shannon Elaine MaryPres., Global Supply & Quality | Sale | 3,978 | $68.02K | Form 4 |
| Aug 10, 2026 | Greenway Nicola Deidre PetalChief Human Resources Officer | Sale | 33,628 | $588.72K | Form 4 |
| Aug 10, 2026 | Greenway Nicola Deidre PetalChief Human Resources Officer | Sale | 975 | $17.06K | Form 4 |
| Aug 10, 2026 | Furney Natalie Anne MarieGlobal General Counsel | Sale | 30,868 | $527.84K | Form 4 |
| Aug 10, 2026 | Platford Giles RichardPresident, IBU | Sale | 31,083 | $531.52K | Form 4 |
| Aug 10, 2026 | Pignagnoli Agosti MarcelloHead, Strat. & Port. Dev | Sale | 22,957 | $392.56K | Form 4 |
| Aug 10, 2026 | Plump Andrew StewartPresident, R&D | Sale | 165,393 | $2.83M | Form 4 |
| Aug 10, 2026 | Ricci GabrieleChief Data & Tech. Officer | Sale | 25,088 | $429.00K | Form 4 |
| Aug 10, 2026 | Pacheco Rhonda JanicePresident, U.S. Business Unit | Sale | 16,901 | $289.01K | Form 4 |
| Aug 10, 2026 | Bitetti Teresa MariePresident, OBU | Sale | 50,012 | $855.21K | Form 4 |
| Aug 10, 2026 | Ibrahim Ramy Riad AhmedPresident, PDT BU | Sale | 7,277 | $124.44K | Form 4 |
| Aug 10, 2026 | Farajallah Awny Samaan BotrosChief Medical Officer | Sale | 14,006 | $239.50K | Form 4 |
| Aug 10, 2026 | Duprey Lauren RusckowskiChief Transformation Officer | Sale | 47,586 | $813.72K | Form 4 |
| Jul 1, 2026 | Shannon Elaine MaryPres., Global Supply & Quality | Award | 30,094 | — | Form 4 |
| Jul 1, 2026 | Ricci GabrieleChief Data & Tech. Officer | Award | 37,616 | — | Form 4 |
| Jul 1, 2026 | Pacheco Rhonda JanicePresident, U.S. Business Unit | Award | 50,156 | — | Form 4 |
| Jul 1, 2026 | Duprey Lauren RusckowskiChief Transformation Officer | Award | 45,140 | — | Form 4 |
| Jul 1, 2026 | Furney Natalie Anne MarieGlobal General Counsel | Award | 43,886 | — | Form 4 |
| Jul 1, 2026 | Farajallah Awny Samaan BotrosChief Medical Officer | Award | 17,554 | — | Form 4 |
| Jul 1, 2026 | Pignagnoli Agosti MarcelloHead, Strat. & Port. Dev. | Award | 27,586 | — | Form 4 |
| Jul 1, 2026 | Greenway Nicola Deidre PetalChief Human Resources Officer | Award | 22,570 | — | Form 4 |
| Jul 1, 2026 | Ibrahim Ramy Riad AhmedPresident, PDT BU | Award | 25,078 | — | Form 4 |
| Jul 1, 2026 | Tsusaka MikiDirector | Award | 1,800 | — | Form 4 |
| Jul 1, 2026 | Smoter Jennifer MarieChief Comm. & Gov. Officer | Award | 18,808 | — | Form 4 |
| Jul 1, 2026 | Kimura KoichiroDirector | Award | 1,800 | — | Form 4 |
| Jul 1, 2026 | BROUSSARD BRUCE DDirector | Award | 3,800 | — | Form 4 |
| Jul 1, 2026 | Platford Giles RichardPresident, IBU | Award | 49,558 | — | Form 4 |
| Jul 1, 2026 | Furuta MilanoChief Financial Officer | Award | 12,300 | — | Form 4 |
| Jul 1, 2026 | Miyabashira AsukaPresident, Japan Pharma B.U. | Award | 1,500 | — | Form 4 |
| Jul 1, 2026 | Reed Kimberly A.Director | Award | 3,800 | — | Form 4 |
| Jul 1, 2026 | MARAGANORE JOHNDirector | Award | 3,800 | — | Form 4 |
| Jul 1, 2026 | Stoffels PaulusDirector | Award | 3,800 | — | Form 4 |
| Jul 1, 2026 | GILLIS STEVENDirector | Award | 3,800 | — | Form 4 |
| Jul 1, 2026 | Iijima MasamiDirector | Award | 1,800 | — | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4